Market News

Green Thumb Industries Announces Conference Participation for April 2022

Green Thumb Industries Inc. ("Green Thumb") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE dispensaries, today announced its executive team will participate in the following conferences in April 2022:

BTIG Global Virtual Cannabis Conference, April 6 – April 7, 2022: Management will participate in one-on-one meetings.

2 nd Annual Cantor Virtual Cannabis Conference, April 12 – April 14, 2022 : Management will participate in one-on-one meetings.

About Green Thumb Industries :

Green Thumb Industries Inc. ("Green Thumb"), a national cannabis consumer packaged goods company and retailer, promotes well-being through the power of cannabis while giving back to the communities in which it serves. Green Thumb manufactures and distributes a portfolio of branded cannabis products including Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles and RYTHM. The company also owns and operates rapidly growing national retail cannabis stores called RISE. Headquartered in Chicago, Illinois, Green Thumb has 17 manufacturing facilities, 76 open retail locations and operations across 15 U.S. markets. Established in 2014, Green Thumb employs approximately 3,800 people and serves millions of patients and customers each year. The company was named to Crain's Fast 50 list in 2021 and a Best Workplace by MG Retailer magazine in 2018, 2019 and 2021. More information is available at www.GTIgrows.com.

Investor Contact: Media Contact:
Andy Grossman Grace Bondy
EVP, Capital Markets & Investor Relations Manager, Corporate Communications
InvestorRelations@gtigrows.com gbondy@gtigrows.com
310-622-8257 517-672-8001

Source: Green Thumb Industries


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

GTII:CNX,GTBIF
The Conversation (0)
Creso Pharma

Wholly-Owned Subsidiary, Mernova Medicinal Inc. Continues Strong Progress In Q2 Securing C$593,926 In New Purchase Orders During May

Creso Pharma Limited (ASX:CPH, FRA:1X8) (‘Creso Pharma’ or ‘the Company’) is pleased to provide the following update on progress through wholly-owned Canadian subsidiary, Mernova Medicinal Inc. (‘Mernova’), which has continued to achieve strong growth in purchase orders in May, as well as an extension of licenses with Health Canada and Canada Revenue Agency.

Keep reading...Show less

Trulieve Announces Opening of Affiliated Medical Marijuana Dispensary in Limerick, PA

New dispensary expands patient access to medical cannabis with ribbon cutting and pop-up event

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today announced the grand opening of a new Trulieve-affiliated medical marijuana dispensary in Limerick, PA. Located at 451 West Ridge Pike, the doors will open 9 AM on Friday, May 19 2023 with ongoing hours of 9 AM - 10 PM seven days a week.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
  Creso Pharma

Creso Pharma Secures Firm Commitments To Raise $2.5M, Extends Secured Notes And Streamlines Balance Sheet With Debt To Equity Conversions

Creso Pharma Limited (ASX:CPH, FRA:1X8) (‘Creso Pharma’ or ‘the Company’) is pleased to advise that it has secured firm commitments from institutional, professional and sophisticated investors to raise $2.5m million (before costs) through the issue of 204,918,033 new fully paid ordinary shares (“Shares”) at an issue price of $0.0122 per Share (the “Placement”). As well, the Company has converted a number of current liabilities to equity, agreed to repay convertible notes to Obsidian Global GP, LLC (“Obsidian”) and agreed in principle to extend its existing Secured Notes with investors.

Keep reading...Show less

Goodness Growth Holdings Announces First Quarter 2023 Results

Q1 revenue of $19.1 million increased 22.1% YoY and 30.5% excluding discontinued operations –

– Cost controls and operational improvements drive second consecutive quarter of positive income from operations –

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Cronos Group Inc. to Speak at the Canaccord Genuity 7th Annual Global Cannabis Conference

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company"), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the Canaccord Genuity 7 th Annual Global Cannabis Conference on Thursday, May 18, 2023, at 11:00AM ET.

A live webcast will be available on the Investors section of the Company's website at https://ir.thecronosgroup.com/events-presentations .

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×